BridgeMD
New treatment option for Carotid Stenosis
Official title Carotid Atherosclerosis : Innovative Imaging Biomarkers. Study Case-control
ClinicalTrials.gov ID: NCT02748941
What this study is testing
- What it's testing
- Cerebrovascular accident (CVA) constitutes a major health public problem. This represents the second cardiovascular death cause.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Carotid stenosis ≥ 50% NASCET
- Case: ipsilateral carotid stenosis stroke, certified by MRI or CT in the preceding month, with no others causes of stroke
- Control: no clinical sign or MRI hint for a recent stroke
- Signed informed consent form
- Patient affiliated to a social security system or equivalent
You likely can't join if
- Modified Rankin scale \> 3
- Homolateral stroke or TIA \> 1 month
- Medical history of homolateral carotid surgery, cervical radiation, carotid occlusive, homolateral intracranial stenosis, risk of developing arterial...
- Renal failure (creatinine clearance \< 50 ml/min)
- Contraindication to ultrasound (sonovue)
- Contraindication to MRI and its contrast media (Gadolinium)
See the full eligibility criteria
- Carotid stenosis ≥ 50% NASCET
- Case: ipsilateral carotid stenosis stroke, certified by MRI or CT in the preceding month, with no others causes of stroke
- Control: no clinical sign or MRI hint for a recent stroke
- Signed informed consent form
- Patient affiliated to a social security system or equivalent
- Modified Rankin scale \> 3
- Homolateral stroke or TIA \> 1 month
- Medical history of homolateral carotid surgery, cervical radiation, carotid occlusive, homolateral intracranial stenosis, risk of developing arterial thromboembolic events
- Renal failure (creatinine clearance \< 50 ml/min)
- Contraindication to ultrasound (sonovue)
- Contraindication to MRI and its contrast media (Gadolinium)
- Inability to sign informed consent
- Inability to undergo any of the technics (claustrophobia…)
- Serious co-morbid disease, dementia
- Neurological disease with no carotid disease
- Risk of pregnancy or pregnancy or breastfeeding
- Adult under reinforced guardianship or legal guardian
- Patient not understanding French
The study team makes the final eligibility decision.
Where it's taking place
- Bron, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.